Literature DB >> 24179886

Alveolar Gas Exchange and Pulmonary Functions in Patients with Type II Diabetes Mellitus.

Anandhalakshmi S1, Manikandan S, Ganeshkumar P, Ramachandran C.   

Abstract

BACKGROUND: The incidence of diabetes is increasing tremendously throughout the world especially in the developing countries. This disease affects various organs like eyes, nerves, kidneys and the heart. In this study, we investigated whether lungs are also one of the target organs of diabetes mellitus or not. AIM: To assess the pulmonary function parameters including alveolar gas exchange in patients with Type 2 Diabetes mellitus and to find the influence of hyperglycaemia and duration of diabetes.
METHODOLOGY: This cross sectional study involved 30 type II diabetic patients of age 30-60 years attending the diabetic outpatient department of SRM Medical College & Research Centre and 30 age and sex matched non-diabetic subjects as controls. The glycated haemoglobin (HbA1c) levels, fasting and post prandial blood glucose levels, pulmonary function parameters such as Forced Vital Capacity (FVC), Forced Expiratory Volume in 1 second (FEV1), Forced Expiratory Volume Percentage (FEV1 /FVC), Peak Expiratory Flow Rate (PEFR), Forced Expiratory Flow (25 - 75%), Peak Inspiratory flow ( PIF), Forced Inspiratory Vital Capacity ( FIVC), Total Lung Capacity ( TLC),Diffusing capacity of lung for carbon monoxide( DLCO) were measured for all the participants using Easyone Pro computerised spirometer. DLCO was measured by single breath Carbon Monoxide (CO) diffusion test. The alveolar membrane permeability was assessed by evaluating the ratio of DLCO to Alveolar Ventilation (VA).
RESULTS: The pulmonary function parameters FVC, FEV1, PEFR, PIF, FIVC, TLC , DLCO and DLCO/VA were significantly low (p<0.05) in patients with type II diabetes mellitus when compared to control group. The DLCO and DLCO/VA were significantly lower (p<0.05) in patients with poor glycemic control(HbA1c > 7).
CONCLUSION: We conclude that the pulmonary function parameters like FVC, FEV1, PEFR, PIF, FIVC, TLC and alveolar gas exchange were significantly reduced in patients with type II diabetes. The patients with Type II diabetes mellitus had a restrictive pattern of respiratory abnormality. The patients with poor glycaemic control( HbA1c > 7) had reduced alveolar diffusion which was not dependent on the duration of diabetes. The impaired respiratory function may give way for the development of pulmonary complications. Spirometry can be used as a screening tool among diabetics as an early preventive measure.

Entities:  

Keywords:  Alveolar gas exchange; Pulmonary Function Tests; Type II Diabetes Mellitus

Year:  2013        PMID: 24179886      PMCID: PMC3809625          DOI: 10.7860/JCDR/2013/6550.3339

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  23 in total

1.  Pulmonary functions in patients with type 2 diabetes mellitus & correlation with anthropometry & microvascular complications.

Authors:  Sanjeev Sinha; R Guleria; A Misra; R M Pandey; R Yadav; Sumit Tiwari
Journal:  Indian J Med Res       Date:  2004-02       Impact factor: 2.375

2.  Deterioration of lung functions in type II diabetic subjects from Northern India.

Authors:  Vinay Agarwal; Bhavyesh Gupta; Pratibha Dev; Yogesh Kumar; Nisar Ahmad; K K Gupta
Journal:  Indian J Physiol Pharmacol       Date:  2009 Apr-Jun

3.  Abnormalities of pulmonary function in patients with non-insulin-dependent diabetes mellitus.

Authors:  H Mori; M Okubo; M Okamura; K Yamane; S Kado; G Egusa; T Hiramoto; H Hara; M Yamakido
Journal:  Intern Med       Date:  1992-02       Impact factor: 1.271

4.  Pulmonary function in non-insulin-dependent diabetes mellitus.

Authors:  M Marvisi; L Bartolini; P del Borrello; M Brianti; G Marani; A Guariglia; A Cuomo
Journal:  Respiration       Date:  2001       Impact factor: 3.580

5.  Reduced diffusion lung capacity in patients with type 2 diabetes mellitus predicts hospitalization for pneumonia.

Authors:  Oana L Klein; Lewis J Smith; Matthew Tipping; Jie Peng; Mark V Williams
Journal:  Diabetes Res Clin Pract       Date:  2011-01-14       Impact factor: 5.602

6.  Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections.

Authors:  H King; R E Aubert; W H Herman
Journal:  Diabetes Care       Date:  1998-09       Impact factor: 19.112

7.  Diminished alveolar microvascular reserves in type 2 diabetes reflect systemic microangiopathy.

Authors:  William W Chance; Chanhaeng Rhee; Cuneyt Yilmaz; D Merrill Dane; M Lourdes Pruneda; Philip Raskin; Connie C W Hsia
Journal:  Diabetes Care       Date:  2008-05-20       Impact factor: 19.112

8.  Bronchial reactivity in diabetic patients. Relationship to duration of diabetes and degree of glycemic control.

Authors:  M P Villa; E Cacciari; F Bernardi; A Cicognani; S Salardi; F Zapulla
Journal:  Am J Dis Child       Date:  1988-07

9.  Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Diabetes Study.

Authors:  Wendy A Davis; Matthew Knuiman; Peter Kendall; Valerie Grange; Timothy M E Davis
Journal:  Diabetes Care       Date:  2004-03       Impact factor: 19.112

10.  Pulmonary function tests in type 2 diabetes mellitus and their association with glycemic control and duration of the disease.

Authors:  Swati H Shah; Pranali Sonawane; Pradeep Nahar; Savita Vaidya; Sundeep Salvi
Journal:  Lung India       Date:  2013-04
View more
  14 in total

1.  Assessment of lung function by spirometry and diffusion study and effect of glycemic control on pulmonary function in type 2 diabetes mellitus patients of the eastern India.

Authors:  Salim Uz-Zaman; Joyashree Banerjee; Anilbaran Singhamahapatra; Pranab Kumar Dey; Anindya Roy; Kaushik Roy; Kakali Roy Basu
Journal:  J Clin Diagn Res       Date:  2014-11-20

2.  Prolonged postoperative respiratory support after proximal thoracic aortic surgery: Is deep hypothermic circulatory arrest a risk factor?

Authors:  Matthew A Schechter; Asad A Shah; Brian R Englum; Judson B Williams; Asvin M Ganapathi; John D Davies; Ian J Welsby; G Chad Hughes
Journal:  J Crit Care       Date:  2015-11-06       Impact factor: 3.425

3.  The association of normal range glycated hemoglobin with restrictive lung pattern in the general population.

Authors:  Il Hwan Oh; Jung Hwan Park; Chang Hwa Lee; Joon-Sung Park
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

4.  Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohort.

Authors:  Kathrin Kahnert; Tanja Lucke; Frank Biertz; Andreas Lechner; Henrik Watz; Peter Alter; Robert Bals; Jürgen Behr; Rolf Holle; Rudolf M Huber; Stefan Karrasch; Beate Stubbe; Margarethe Wacker; Sandra Söhler; Emiel F M Wouters; Claus Vogelmeier; Rudolf A Jörres
Journal:  Respir Res       Date:  2017-01-13

5.  The effect of alogliptin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy.

Authors:  He Tai; Ming-Yue Wang; Yue-Ping Zhao; Ling-Bing Li; Qian-Yan Dong; Xin-Guang Liu; Jin-Song Kuang
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

6.  Relationship between pulmonary function and albuminuria in type 2 diabetic patients with preserved renal function.

Authors:  Yun-Yun He; Zhe Chen; Xiang-Yang Fang; Jing Chang; Yong Lu; Xiao-Juan Wang
Journal:  BMC Endocr Disord       Date:  2020-07-23       Impact factor: 2.763

Review 7.  Endothelial activation and dysfunction in metabolic syndrome, type 2 diabetes and coronavirus disease 2019.

Authors:  Melvin R Hayden
Journal:  J Int Med Res       Date:  2020-07       Impact factor: 1.671

8.  Pulmonary function tests in type 2 diabetes: a meta-analysis.

Authors:  Jesús Díez-Manglano; Uxua Asìn Samper
Journal:  ERJ Open Res       Date:  2021-02-01

9.  Type II diabetes accentuates diaphragm blood flow increases during submaximal exercise in the rat.

Authors:  Alec L E Butenas; Joshua R Smith; Steven W Copp; K Sue Hageman; David C Poole; Timothy I Musch
Journal:  Respir Physiol Neurobiol       Date:  2020-08-07       Impact factor: 1.931

10.  Effect of Glycated Hemoglobin (HbA1c) and Duration of Disease on Lung Functions in Type 2 Diabetic Patients.

Authors:  Hawra Bin Maan; Sultan Ayoub Meo; Fawziah Al Rouq; Imran Muhammad Umar Meo; Milagros E Gacuan; Joud Mohammed Alkhalifah
Journal:  Int J Environ Res Public Health       Date:  2021-06-29       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.